(Credit: SIP, Guy Luethy et al.) Where SIP Lab’s DeltaPen comes in as an attempt at a smart pen that acts more like the pen of a drawing tablet, just minus the tablet. This project is related to ...
ND02 is under clinical development by HK inno.N and currently in Phase II for Glaucoma. According to GlobalData, Phase II drugs for Glaucoma have a 39% phase transition success rate (PTSR) indication ...